erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
more stories from investigations
.
the house has passed an order extending the public health committee's reporting deadline for cusack's bill.
.
.